ArticleJournal of clinical and experimental hematopathology : JCEH2021

Burkitt leukemia with precursor B-cell features that developed after ruxolitinib treatment in a patient with hydroxyurea-refractory JAK2

Katsuhiro Fukutsuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.